title: How should we understand the term androgen deprivation therapy?
authors.forename: Tomasz
authors.initials: T
authors.lastname: Drewa
authors.forename: Mark S
authors.initials: MS
authors.lastname: Soloway
mesh_terms: D000726:Androgen Antagonists / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000097:blood; D032882:Comprehension; D006801:Humans; D008297:Male; D009376:Neoplasms, Hormone-Dependent / Q000097:blood / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D009919:Orchiectomy; D011471:Prostatic Neoplasms / Q000097:blood / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D009626:Terminology as Topic; D013739:Testosterone / Q000037:antagonists & inhibitors* / Q000097:blood
chemical_list: D000726:Androgen Antagonists; D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D013739:Testosterone